113 related articles for article (PubMed ID: 2481944)
1. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.
Okunishi H; Spragg J; Burton J; Toda N
Adv Exp Med Biol; 1989; 247B():23-8. PubMed ID: 2481944
[TBL] [Abstract][Full Text] [Related]
2. In vivo assay of specific kallikrein inhibitors.
Okunishi H; Spragg J; Burton J
Agents Actions Suppl; 1987; 22():381-90. PubMed ID: 3481213
[TBL] [Abstract][Full Text] [Related]
3. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.
Deshpande MS; Burton J
J Med Chem; 1992 Aug; 35(17):3094-102. PubMed ID: 1507198
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
[TBL] [Abstract][Full Text] [Related]
5. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins.
Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S
J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
[TBL] [Abstract][Full Text] [Related]
12. A systematic approach for determining minimum inhibitory sequence and contribution of individual residues in binding of kininogen fragments to tissue kallikrein.
Deshpande MS; Burton J
Agents Actions Suppl; 1992; 38 ( Pt 1)():210-6. PubMed ID: 1466273
[TBL] [Abstract][Full Text] [Related]
13. Rat uterine contraction by kallikrein and its dependence on uterine kininogen.
Figueiredo AF; Salgado AH; Siqueira GR; Velloso CR; Beraldo WT
Biochem Pharmacol; 1990 Feb; 39(4):763-7. PubMed ID: 1689579
[TBL] [Abstract][Full Text] [Related]
14. Specificity of substrate analogue inhibitors of human urinary kallikrein.
Okunishi H; Burton J; Spragg J
Hypertension; 1985; 7(3 Pt 2):I72-5. PubMed ID: 3846567
[TBL] [Abstract][Full Text] [Related]
15. The myostimulating effect of tissue kallikrein on rat uterus.
Damas J; Bourdon V; Pinto JC
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):535-41. PubMed ID: 7643918
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
17. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
Dumke CL; Kim J; Arias EB; Cartee GD
J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice is a low molecular weight kininogen. Partial NH2- and COOH-terminal sequences and susceptibility to various glandular kallikreins.
Sueyoshi T; Uwani M; Itoh N; Okamoto H; Muta T; Tokunaga F; Takada K; Iwanaga S
J Biol Chem; 1990 Jun; 265(17):10030-5. PubMed ID: 2351646
[TBL] [Abstract][Full Text] [Related]
19. Determinants of tissue kallikrein cleavage specificity in the limited proteolysis of kininogens.
Prado ES; Chao J; Chagas JR; Juliano MA; Juliano L
Agents Actions Suppl; 1992; 38 ( Pt 1)():74-81. PubMed ID: 1466305
[TBL] [Abstract][Full Text] [Related]
20. Characterization of serine proteinases isolated from rat submaxillary gland: with special reference to the degradation of rat kininogens by these enzymes.
Kato H; Nakanishi E; Enjyoji K; Hayashi I; Oh-ishi S; Iwanaga S
J Biochem; 1987 Dec; 102(6):1389-404. PubMed ID: 3482210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
